Published in Environ Health Perspect on March 01, 1986
Transition metal-binding proteins from three Chesapeake Bay fish species. Environ Health Perspect (1986) 0.77
Ligand substitution reactions of metallothioneins with EDTA and apo-carbonic anhydrase. Proc Natl Acad Sci U S A (1980) 1.57
Structure of an invertebrate metallothionein from Scylla serrata. J Biol Chem (1982) 1.56
Characterization of isoprotein patterns in tissue extracts and isolated samples of metallothioneins by reverse-phase high-pressure liquid chromatography. Biochem J (1983) 1.38
Purification and properties of plaice metallothionein, a cadmium-binding protein from the liver of the plaice (Pleuronectes platessa). Biochem J (1979) 1.33
Investigation of the structure of metallothioneins by proton nuclear magnetic resonance spectroscopy. Biochemistry (1980) 1.32
High resolution 1H n.m.r. studies of vertebrate blood and plasma. Biochem J (1983) 1.18
113Cd NMR studies of reconstituted seven-cadmium metallothionein: evidence for structural flexibility. Biochemistry (1985) 1.13
Occurrence of cadmium in crabs (Cancer pagurus) and the isolation and properties of cadmium metallothionein. Environ Health Perspect (1986) 0.99
Use of 2-mercaptoethanol during chromatography of crab (Cancer pagurus) metallothionein on DEAE cellulose. Comp Biochem Physiol C (1984) 0.89
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science (1986) 12.49
Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol (1985) 7.35
Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol (1986) 5.31
In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol (1986) 4.12
Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes. FEBS Lett (2001) 3.88
Cadmium-Resistant Pseudomonas putida Synthesizes Novel Cadmium Proteins. Science (1984) 2.07
Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. J Clin Invest (1984) 2.07
Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol (2000) 2.07
An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett (2000) 1.74
Inhibition of cancer cell growth by ruthenium(II) arene complexes. J Med Chem (2001) 1.61
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem (1989) 1.54
Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Ann Intern Med (1985) 1.53
Comparison of T and B cell analyses on fresh and aged blood. J Immunol Methods (1984) 1.53
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. Br J Cancer (2002) 1.45
Cisplatin binding sites on human albumin. J Biol Chem (1998) 1.45
Vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics. Physiol Genomics (2002) 1.45
Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. J Immunol (1989) 1.42
Uraemia: is urea more important than we think? Lancet (1991) 1.42
In-vitro identification of distinctive metabolic signatures of intact varicose vein tissue via magic angle spinning nuclear magnetic resonance spectroscopy. Eur J Vasc Endovasc Surg (2012) 1.41
Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett (2002) 1.39
Patients' attitudes to xenotransplantation. Lancet (1997) 1.38
Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections. N Engl J Med (1993) 1.38
Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia (2007) 1.34
Purification and properties of plaice metallothionein, a cadmium-binding protein from the liver of the plaice (Pleuronectes platessa). Biochem J (1979) 1.33
Probing latent biomarker signatures and in vivo pathway activity in experimental disease states via statistical total correlation spectroscopy (STOCSY) of biofluids: application to HgCl2 toxicity. J Proteome Res (2006) 1.27
Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem (1984) 1.26
Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem Res Toxicol (1998) 1.26
Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta (1991) 1.24
Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett (1987) 1.24
750 MHz 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharm Biomed Anal (1997) 1.22
Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem Res Toxicol (2001) 1.20
High resolution 1H n.m.r. studies of vertebrate blood and plasma. Biochem J (1983) 1.18
Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J (1984) 1.17
Biosafety guidelines for sorting of unfixed cells. Cytometry (1997) 1.16
Metabonomic investigations into hydrazine toxicity in the rat. Chem Res Toxicol (2001) 1.15
113Cd NMR studies of reconstituted seven-cadmium metallothionein: evidence for structural flexibility. Biochemistry (1985) 1.13
Curve-fitting method for direct quantitation of compounds in complex biological mixtures using 1H NMR: application in metabonomic toxicology studies. Anal Chem (2005) 1.12
Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal Biochem (1994) 1.12
Transferrin as a metal ion mediator. Chem Rev (1999) 1.11
High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn Reson Med (2000) 1.10
Characterisation of cadmium-binding proteins from mussels, Mytilus edulis (L), exposed to cadmium. Biochim Biophys Acta (1979) 1.09
Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression. J Clin Invest (1987) 1.09
Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem Res Toxicol (2000) 1.09
High-resolution magic angle spinning (1)H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal Biochem (2000) 1.09
NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem Res Toxicol (2001) 1.08
Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody. J Virol (1996) 1.07
Electron transfer between cytochromes c from horse and Pseudomonas. J Biol Chem (1970) 1.06
NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int (1993) 1.05
Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed (1998) 1.05
Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. Anal Biochem (2001) 1.03
The role of gut microbiota in drug response. Curr Pharm Des (2009) 1.03
Adoption of single-platform technologies for enumeration of absolute T-lymphocyte subsets in peripheral blood. Clin Diagn Lab Immunol (2000) 1.03
High-resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn Reson Med (1999) 1.03
Directly coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development. J Chromatogr B Biomed Sci Appl (2000) 1.02
A metallothionein containing a zinc finger within a four-metal cluster protects a bacterium from zinc toxicity. Proc Natl Acad Sci U S A (2001) 1.02
Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal (1998) 1.01
An update on the use of flow cytometry in HIV infection and AIDS. Clin Lab Med (2001) 1.01
Multi-metal binding site of serum albumin. J Inorg Biochem (1998) 1.01
High-resolution (1)H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue. Magn Reson Med (2001) 1.01
Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. Mol Pharmacol (1985) 1.00
Monitoring metabolic disease by proton NMR of urine. Lancet (1984) 1.00
Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride. Biochemistry (2000) 0.99
Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J Clin Immunol (1985) 0.99
Occurrence of cadmium in crabs (Cancer pagurus) and the isolation and properties of cadmium metallothionein. Environ Health Perspect (1986) 0.99
Cytotoxicity and antitumor activity of some tetrahedral bis(diphosphino)gold(I) chelates. J Med Chem (1990) 0.99
A cadmium-binding glycoprotein from the liver of the plaice (Pleuronectes platessa). Biochem Soc Trans (1977) 0.98
Interlobe communication in 13C-methionine-labeled human transferrin. Biochemistry (1996) 0.98
Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning (1)H NMR spectroscopy. Magn Reson Med (2001) 0.97
1H,13C-NMR and X-ray absorption studies of copper(I) glutathione complexes. Eur J Biochem (1996) 0.97
Interactions of bismuth complexes with metallothionein(II). J Biol Chem (1999) 0.97
Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. Mol Pharmacol (1991) 0.97
High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim Biophys Acta (1992) 0.96
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model. J Inorg Biochem (2009) 0.96
1H NMR studies of human blood plasma. Assignment of resonances for lipoproteins. FEBS Lett (1987) 0.95
Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples. J Pharm Biomed Anal (1994) 0.95
In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Cancer Res (1986) 0.95
Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of (1)H magic angle spinning (MAS) NMR spectra. NMR Biomed (2000) 0.94
High resolution 1H NMR spectroscopic studies on dynamic biochemical processes in incubated human seminal fluid samples. Biochim Biophys Acta (1998) 0.94
Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition. Biomarkers (2005) 0.94
Biosafety considerations for flow cytometric analysis of human immunodeficiency virus-infected samples. Cytometry (1999) 0.94
Direct observation of resolved intracellular and extracellular water signals in intact human red blood cells using 1H MAS NMR spectroscopy. Magn Reson Med (1997) 0.94
750 MHz 1H-NMR spectroscopy of human blood plasma. J Pharm Biomed Anal (1993) 0.94
1H NMR structure of an antifungal gamma-thionin protein SIalpha1: similarity to scorpion toxins. Proteins (1998) 0.93
Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: comparison with copper and gold. J Inorg Biochem (1988) 0.93
A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy. Ann Oncol (2011) 0.93
Metabolic profiling of genetic disorders: a multitissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal Biochem (2001) 0.92
Analysis of biological fluids using 600 MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. J Pharm Biomed Anal (1993) 0.92
Comparison of monocyte separation methods using flow cytometric analysis. J Immunol Methods (1989) 0.92
Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy. Biochim Biophys Acta (2003) 0.92
The microanatomy of the distal tubules, collecting tubules and collecting ducts of the starling kidney. J Anat (1982) 0.92